Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
about
Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSHSuppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growthNovel therapeutic targets for pancreatic cancerNeuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for interventionLatent bone metastasis in breast cancer tied to Src-dependent survival signalsBile acids: regulation of apoptosis by ursodeoxycholic acidThe anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceEnhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitorsPotential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Ion channels and apoptosis in cancerStructural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5Decoy Strategies: The Structure of TL1A:DcR3 ComplexS-SAD phasing study of death receptor 6 and its solution conformation revealed by SAXSMechanistic Basis for Functional Promiscuity in the TNF and TNF Receptor Superfamilies: Structure of the LIGHT:DcR3 AssemblyRole of nanotechnology and gene delivery systems in TRAIL-based therapiesTL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cellsGeneral Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMACAluminum doping tunes band gap energy level as well as oxidative stress-mediated cytotoxicity of ZnO nanoparticles in MCF-7 cellsMechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cellsIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceTargeting tumour-initiating cells with TRAIL based combination therapy ensures complete and lasting eradication of multiple myeloma tumours in vivoPI3K/AKT Signaling Pathway Is Essential for Survival of Induced Pluripotent Stem CellsThe Fas/Fas ligand death receptor pathway contributes to phenylalanine-induced apoptosis in cortical neuronsSuperior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivityH5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells.Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.The Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity.Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies.Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.TRAIL mutant membrane penetrating peptide alike-MuR6-TR enhances the antitumor effects of TRAIL in pancreatic carcinoma both in vitro and in vivo.Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts.Andrographolide induces apoptotic and non-apoptotic death and enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in gastric cancer cells.Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway.Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cellsCoxiella burnetii Nine Mile II proteins modulate gene expression of monocytic host cells during infectionEarly growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.Targeting a novel N-terminal epitope of death receptor 5 triggers tumor cell death.
P2860
Q24303547-D2F5ECFF-F822-475F-9DFC-E756B062D42EQ24328839-E32010C5-C37E-4763-8087-FFF2FB46FC50Q24564267-8FB30DA8-139F-4072-9F03-0FA1781DA109Q24570124-47E4C50A-D16F-4580-AB13-31B088962A94Q24648828-FC219055-4C81-416B-A640-16850D84BEE1Q24653969-E68AD695-4BF2-4B5F-A929-524A66710168Q24811656-EE543E76-7C7B-4DEA-8A92-B687B05C8FBBQ26768267-FFCBCDFB-7A8E-403D-A3AF-BEB6CB465FE0Q26771601-B2D68C6F-0903-4698-AC04-37C0C72201C7Q27005947-514649B9-4A93-45B7-9E0E-04C6410914F2Q27649718-533ABC83-6870-438D-8DFE-2DF901EA6946Q27666869-F18D919E-D2D8-40BE-983A-82BA40174902Q27678676-026A0CF8-992F-436A-A8C6-77BD013430A1Q27684921-AEDAE441-4C6E-486F-B928-C7C0CD83C5C2Q28076798-77317575-E1B3-4609-9D93-36FCC7C460DCQ28189886-3E230761-51CC-4627-BE29-64E728E62087Q28385542-93C56F7F-2FB5-41A8-A811-BB5940D24AC6Q28387963-1340843C-BD6C-499E-88B7-8DC4CBE526A0Q28392953-11A7A5FF-5D47-454E-BAC2-F404612DD84EQ28396942-9B17F9B5-67D5-42FE-88A7-CCFD608468D5Q28478469-B532886C-44D6-48A9-898E-33D56EEE692AQ28483760-FA9B499D-A41D-4017-9599-2C9B76ECDE17Q28551735-226B7F00-7E0C-424F-B1CC-FEBBD67DCA44Q28572083-C32B3353-43EB-4F04-9313-20F1B0B993A9Q28729760-7C545A16-59AD-4789-A5D8-F8852CA30994Q30372027-AF5CFD1D-A868-46B6-993F-2EF597AA42C2Q30440458-59D6C64F-A08A-417D-9308-A4072C831CD4Q30486741-944556EF-554B-4E47-9FB1-5CF564BC9A9BQ30500787-06BAD2E9-0CA1-4C61-AD23-B85285885243Q30571484-38C48B97-4671-46DC-B505-9272ED12CD07Q33255121-ED0046F1-9515-470F-B7C9-7202FC20DCCEQ33288897-EBD63AF0-281E-41BB-AF4F-AEC2DFA5B2E4Q33674881-B554837D-D35E-4059-BED3-D0FAA9FB413DQ33680928-A3D3EF27-8EDB-4D48-9F66-15100C046420Q33685962-F35B2CAA-CD8A-49FB-9493-75095CD1A4E3Q33688881-43404228-6E39-484A-BA1E-9B46301189B6Q33689870-F73286A3-13E9-4B85-BE61-D84D41F1D9A4Q33696616-08CD9FFB-1983-444B-B4E9-D1438D0BF2FCQ33723716-34D8613F-B2B0-4612-803B-6FC660711C31Q33726537-4AEBDC1E-E7BF-40B2-98CC-C0924225813B
P2860
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@ast
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@en
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@nl
type
label
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@ast
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@en
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@nl
prefLabel
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@ast
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@en
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@nl
P356
P1476
Targeting death and decoy receptors of the tumour-necrosis factor superfamily.
@en
P2093
Avi Ashkenazi
P2888
P304
P356
10.1038/NRC821
P407
P577
2002-06-01T00:00:00Z
P5875
P6179
1047196539